🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Drug Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are encouraged to message these profiles privately for source information, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and assertions of next-day UK delivery. Sellers market the substance there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to individuals administering products of uncertain source.

Some professionals stated the popularity for the experimental drug could be connected to the increasing cost of approved slimming products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate medicines, marketing, and customer regulations, risking fines, legal action or prison.

Platform Reaction and Content Elimination

Based on TikTok, the service has removed problematic material and banned related keywords and search suggestions. The organization stated it was dedicated to maintaining the platform secure and allocating resources in strengthening compliance measures.

Digital Marketplace Operations

Investigations also discovered groups with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, populated with photos of slimming results, glowing reviews and detailed guides for mixing or administering at home.

After moments of entering one group, a seller posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, health issues or previous experience.

Item Information and Costs

Within these communities, posts show dark colored packages with Royal Mail labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors typically sold at £160 for 20mg. When questioned how much time a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these digital versions may not include what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.

Her team has previously seen patients harmed by self-injection from unverified sources. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Position

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to potentially significant health risks”.